Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BETASERON for Secondary progressive multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where BETASERON was used for Secondary progressive multiple sclerosis.

Most Reported Side Effects for BETASERON

Side Effect Reports % Deaths Hosp.
Influenza like illness 65 11.0% 0 2
Injection site pain 43 7.3% 0 3
Drug ineffective 41 6.9% 0 0
Multiple sclerosis relapse 41 6.9% 1 8
Multiple sclerosis 38 6.4% 1 5
Injection site erythema 35 5.9% 0 1
Depression 33 5.6% 0 2
Fatigue 29 4.9% 0 2
Drug dose omission 22 3.7% 0 5
Injection site bruising 22 3.7% 0 2
Injection site mass 22 3.7% 0 1
Injection site reaction 22 3.7% 0 0
Hypoaesthesia 21 3.6% 0 4
Gait disturbance 20 3.4% 0 0
Chills 19 3.2% 0 1

Other Indications for BETASERON

Multiple sclerosis (367) Relapsing-remitting multiple sclerosis (71) Product used for unknown indication (19)

Other Drugs Used for Secondary progressive multiple sclerosis

SIPONIMOD (2,265) OCRELIZUMAB (1,273) OFATUMUMAB (1,099) FINGOLIMOD (351) INTERFERON BETA-1B (146) RITUXIMAB (131) NATALIZUMAB (115) DIMETHYL (96) INTERFERON BETA-1A (89) RABEPRAZOLE (86)

Related Pages

BETASERON Full Profile All Secondary progressive multiple sclerosis Drugs BETASERON Demographics BETASERON Timeline